Potassium Repletion: IV vs. PO

Slides:



Advertisements
Similar presentations
Using the Insulin Subcutaneous Order & Blood Glucose Record – Adult
Advertisements

Hyponatremia and Other Critical Electrolyte Abnormalities
Electrolyte Disturbance Dr. Khalid Jamal Hamdi.
Cost analysis project : Ordering Magnesium and Phosphorus Pouneh Nasseri R2 12/17/12.
CMS Core Measures Evidence-Based Performance Measurement.
Prescribing Information is available at the end of this presentation NHS Surrey Lipid Guidelines Dr Adam Jacques Ashford & St.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Australian Commission on Safety and Quality in Health Care
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
By Ameya Nerurkar Mandar Samant Chih-Pin Hsiao
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz RRT, MS, Administrative.
Pharmacy 483 Outcomes & Cost Management in Pharmacy Practice Janet Kelly, Pharm.D., BC-ADM February 24, 2004.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
HYPOKALEMIA.
Therapeutic Drug Monitoring (TDM) Sticker Project A New Method for Documenting Times of Medication Doses and Drug Levels.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
HYPOKALEMIA MANAGEMENT
Finding the Evidence Approximately 8,000 completed references are added to MEDLINE each week (over 400,000 added per year) Too much for any one person.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Clinical Cholera Case Management CME PRESENTATION 4/2/16 By Pastory Mondea.
Discharge Summaries.  Discharge Summaries –Can be challenging  What happens during a hospital course is now more complex and more detailed than in the.
Potassium repletion in the CCU: IV vs PO. Background Potassium repletion is commonly performed in the wards and ICU/CCU Normal potassium (per Quest) is.
Viagra (sildenafil citrate): Extensive Clinical and Post-Marketing Experience Michael Sweeney, MD Senior Medical Director Pfizer Inc.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
Clinical Cholera Case Management
Landon Marshall, Pharm. D. , Matt Hill, Pharm. D. , Jim Wilson, Pharm
of Patients with Acute Myocardial Infarction (AMI)
DIAGNOSIS No symptoms = no heart failure. DIAGNOSIS No symptoms = no heart failure.
Management of mitral regurgitation. See legend for Fig
Electrolytes Tutoring (Part 2): calcium, Phosphate, Potassium, and Magnesium By Alaina darby.
Specialist of Clinical pathology Patient safety officer
Clinical need for determination of vulnerable plaques
Maintenance Fluid Prescription
Not Wanting to Miss a Beat – Is it Costing Us?
Copyright © 2006 American Medical Association. All rights reserved.
Introduction to Clinical Pharmacy
Courtney selby, Pharm.d. arcare pgy1 Community pharmacy resident
Electrolytes Tutoring (Part 2): calcium, Phosphate, Potassium, and Magnesium By Alaina darby.
Echocardiograms in syncope work-up
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Regadenoson Use in Chronic Kidney Disease and End-Stage.
Progressing and discharging patients from the intensive care
Paediatric Daily Fluid Prescription & Balance Chart 2017
Adnan Hajjiah Critical Care Pharmacist MSc Clinical Pharmacy, MPharm
Therapeutic Approach to Hyperkalemia
Chapter 1 Benefits and Risks Associated with Physical Activity
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Information provided by: Yvette Mansion-Whittaker
Opioids.
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Contemporary Evidence-Based Guidelines
What is the relative risk reduction of ACEi’s/beta blockers for HFrEF?
Appropriateness of Potassium Repletion on UCI Wards
Evaluation of Rasburicase Administration at University of Iowa Hospitals and Clinics Katie Gaspar, Ahmed Abdeldagir, Christine Behrendt, Michael Boller,
The use of telemetry cardiac monitoring on inpatient wards at UCI
The Case for Routine CYP2C19 ( Plavix® ) Genetic Testing
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Refeeding Syndrome Refeeding is a complication of surgery which is not immediately considered when patients show problems after initiating feeding.
Information provided by: Yvette Mansion-Whittaker
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.
Cardiovascular Epidemiology and Epidemiological Modelling
Principal recommendations
Presentation transcript:

Potassium Repletion: IV vs. PO Stephanie Singson, PGY2

Outline Introduction Evidence Guidelines When to use IV vs. PO Study Question Study Results Discussion Summary

introduction Normal serum potassium level: 3.5 and 5.0 mmol/L. The daily minimum requirement of potassium is considered to be approximately 1600 to 2000 mg (40-50 mmol or mEq). More than 20% of hospitalized patients have hypokalemia (K < 3 .5 mmol/L).

evidence Thomas (1983): The risk of early ventricular fibrillation in acute myocardial infarction is increased in patients with serum potassium less than 3.9 mmol/L. Leier et al (1994): Serum potassium in heart failure should be maintained between 4.5-5.0 mmol/l to minimize the risk of sudden cardiac death. Leier CV Dei Cas LMetra M Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J. 1994;128564- 574

Why do we replete K to 4.0? Consensus Guidelines for Potassium Replacement in Clinical Practice. JAMA, 2000. “Patients with heart disease are often susceptible to life-threatening ventricular arrhythmias […] Such arrhythmias are associated with heart failure, left ventricular hypertrophy, myocardial ischemia, and myocardial infarction (both in the acute phase and after remodeling)” “Maintenance of optimal potassium levels (at least 4.0 mmol/L) is critical in these patients and routine potassium monitoring is obligatory.”

Appropriate Use of IV Guidelines for the treatment of hypokalemia recommend the use of oral agents at a moderate dose, typically between 40 and 200 mmol per day. IV potassium preparations are recommended for treatment of severe cases (K < 2.5) or in symptomatic patients. http://fm.mednet.ucla.edu/IMG/download/PotassiumAndPhosphorusRepletion.pdf

Study Question What percentage of patients on UCI wards had their potassium repleted with an IV preparation while on a diet?

Methods Charts reviewed of all inpatient medicine patients on Teams A-G for potassium administered on 2/12-2/13. Documented level of K, amount and formulation of K given on all patients with active oral or tube feeding orders. Contacted UCI inpatient pharmacy for prices on the various potassium formulations most commonly used on wards.

Cost of Commonly Used Formulations At UCI Medical Center the cost of IV KCl is almost 3-4x times more than oral KCl. Potassium chloride 10meq tab: 35 cents Potassium chloride 20meq oral solution: 56 cents Potassium chloride IV 20meq vial: $2.25 Potassium phosphate IV 4.4meq vial: $16.92 Trillion Dollar Scam: Exploding Health Care Fraud by Saul William Seidman

Results Potassium level Diet IV PO Both Amount given 3.5 Yes x 40meq   40meq 3.1 60meq 3.4 3.2 80meq 3.3 3.8 30meq 3.9 3.0 3.6 yes 2.4 20meq

Results 24 patients on medicine wards had their potassium repleted between 2/12-2/13 All 24 patients had an active diet order: PO or NG tube feeds 9/24 patients were repleted with IV potassium only 12/24 patients were repleted with PO potassium only 2/24 patients were repleted with both IV and PO potassium 45.8% of patients received IV potassium while on a diet

Unnecessary Costs 370 mEq of IV potassium given to floor patients on a diet $41.62 spent on IV potassium/ 24 hours Extrapolated annual cost: $15,193

Discussion Is IV better than PO? Is IV faster than PO? 10 meq/hr via peripheral line Has a discharge ever been delayed because the IV K order is going to take at least 4 hours to complete? http://fm.mednet.ucla.edu/IMG/download/PotassiumAndPhosphorusRepletion.pdf

Limitations Small sample size n=24 Unclear why residents chose IV vs PO. A detailed chart further for EKG changes, symptoms or other manifestations that would be considered a “severe case” was not done.

Summary Current guidelines recommend K repletion to 4.0 in patients with heart disease. Oral potassium chloride is the preferred agent for repletion if patient is tolerating a diet. Use IV potassium for severe symptomatic cases. IV potassium costs 3-4x more than PO. Consider adding an additional step on Quest for potassium repletion options. For example, a box to check off: Is IV Potassium indicated

sources Cohn JN, Kowey PR, Whelton PK, Prisant L. New Guidelines for Potassium Replacement in Clinical Practice: A Contemporary Review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429-2436. doi:10.1001/archinte.160.16.2429. Hemstreet B, Stolpman N et al. Potassium and Phosphorus Repletion in Hospitalized Patients: Implications for Clinical Practice and the Potential Use of Healthcare Information Technology to Improve Prescribing and Patient Safety. Curr Med Research and Opinion. Leier CVDei Cas LMetra M Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J. 1994;128564- 574 Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol. 2004;43(2):155-161. doi:10.1016/j.jacc.2003.06.021. Thomas RD. Ventricular fibrillation and initial plasma potassium in acute myocardial infarction. Postgraduate Medical Journal 1983;59(692):354-356. UCI pharmacy

Thanks!